Neogen Acquires Scidera Genomics
News Jan 07, 2013
Neogen Corporation has announced that it has acquired the assets of Scidera Genomics, LLC, an animal genomics business based in Davis, California.
The company, formerly operated as MetaMorphix, Inc., or MMI Genomics, was a pioneer in the development of cattle, poultry, swine, and canine genetic testing.
Scidera’s predecessor company conducted parentage testing and trait analysis for the cattle and canine industries since DNA was first used in the early 1990s.
The company owns critical patents and other intellectual property in the industry. Scidera also has had successful long-term customer relationships with influential dog breed registries, including the American Kennel Club, and numerous cattle breed associations, including the American Akaushi Association and American Bucking Bull, Inc.
“Scidera’s highly respected technical staff and customer base represent a perfect complement to Neogen’s animal genomics businesses, GeneSeek and Igenity,” said Dr. Jason Lilly, Neogen’s vice president of corporate development.
Dr. Lilly continued, “The combination of these companies within Neogen creates the unquestioned global leader in innovative animal genomics tools and analysis. We now provide value-added services to leading agricultural genetics providers, large national cattle associations, companion animal breed registries, university researchers, and numerous commercial cattle producers.”
The acquisition, effective as of Jan. 1, will be reported as a part of Neogen’s animal safety segment. Terms of the acquisition were not disclosed.
In April 2010, Neogen acquired GeneSeek, then considered the leading commercial agricultural service laboratory in the United States. GeneSeek’s customers included many of the world’s largest animal and animal health companies. In May 2012, Neogen acquired Igenity.
GeneSeek had conducted the genetic testing of samples for Igenity, and Igenity then used that information with its bioinformatics databases to identify the animal’s key production traits.
Acquiring Scidera further adds to the genotyping testing technology Neogen can offer to world-wide animal genomics customers.
Neogen Corporation develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns.
Neogen’s Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.
Giant Viruses Invent Their Own GenesNews
Three new members have been isolated and added to the Pandoravirus family. This strange family of viruses, with their giant genomes and many genes with no known equivalents, surprised scientists when they were discovered a few years ago. This new study notes that pandoraviruses appear to be factories for new genes – and therefore new functions.
Therapeutic CRISPR Could Be Cancer RiskNews
Therapeutic use of gene editing with the so-called CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study. Researchers say that more studies are required in order to guarantee the safety of these ‘molecular scissors’ for gene-editing therapies.
Who Owns the Ocean? One Company Has Registered Half of All Marine Gene PatentsNews
A single corporation has registered nearly half of all existing patents associated with genes from marine organisms, according to a new study. Researchers from the University of British Columbia and the Stockholm Resilience Centre examined the patents associated with marine species and found that BASF, the world’s largest chemical manufacturer, has registered 47 per cent of the 12,998 genetic sequences from 862 marine species.